Gilead Sciences Inc (GILD)
Receivables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 28,754,000 | 27,116,000 | 27,281,000 | 27,305,000 | 24,689,000 |
| Receivables | US$ in thousands | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue ÷ Receivables
= $28,754,000K ÷ $—K
= —
Based on the data provided, it appears that information regarding Gilead Sciences Inc's receivables turnover for the years ranging from December 31, 2020, to December 31, 2024, is unavailable (denoted by '—'). The receivables turnover ratio is a financial metric that reflects the efficiency with which a company is collecting its accounts receivable from customers over a specific period.
In the absence of the actual receivables turnover figures, it is challenging to assess or analyze Gilead Sciences Inc's performance in this aspect. Receivables turnover is typically calculated by dividing net credit sales by the average accounts receivable balance. A higher turnover ratio generally indicates a more efficient collection process and better management of accounts receivable.
Without the specific data for Gilead Sciences Inc's receivables turnover, it is not feasible to provide a detailed analysis or any insights into the company's effectiveness in managing its receivables during the given period. Additional information or financial data would be necessary to evaluate the company's performance in this area accurately.
Peer comparison
Dec 31, 2024